| Product NDC: | 31722-543 |
| Proprietary Name: | Indomethacin |
| Non Proprietary Name: | Indomethacin |
| Active Ingredient(s): | 50 mg/1 & nbsp; Indomethacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 31722-543 |
| Labeler Name: | Camber Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091240 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111101 |
| Package NDC: | 31722-543-30 |
| Package Description: | 12 BOTTLE in 1 CASE (31722-543-30) > 30 CAPSULE in 1 BOTTLE |
| NDC Code | 31722-543-30 |
| Proprietary Name | Indomethacin |
| Package Description | 12 BOTTLE in 1 CASE (31722-543-30) > 30 CAPSULE in 1 BOTTLE |
| Product NDC | 31722-543 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Indomethacin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20111101 |
| Marketing Category Name | ANDA |
| Labeler Name | Camber Pharmaceuticals |
| Substance Name | INDOMETHACIN |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |